Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$APUS

Apimeds Pharmaceuticals US, Inc.

XASE

$8.00+27.19%+$1.71Prev $6.29LIVE Full chart Live alerts
No recent price bars, the chart lights up when APUS starts printing.

Why is APUS up today? It is at $8.00 (+27.19%), and our scanner flagged it 2 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment APUS spikes, and full due diligence on APUS — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $APUS alerts the moment volume spikes

Our scanner flagged $APUS 2 times in the last 30 days. Create a free account to track $APUS, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$8.00
Change today
+27.19%
Previous close
$6.29
52-week range
$0.615 – $40.31
Valuation & dividend
Market cap
$9M
Ownership & volume
Shares outstanding
15.1M
SEC · as of 2026-05-26
Institutional own.
3.36%
Total held
3.4%
Tradeable float
14.6M
97% of shares · after 3% institutions
Short interest
176K
▼ -24% vs prior · as of 2026-07-15
Short % of float
1.2%
Days to cover
1.0d
Avg daily volume
65K
Next earnings
Aug 18 · in 21d
Classification
Exchange
XASE
Relative volumevs this time of day
5m
--
15m
--
1h
--
1D
0.0x

Get free APUS + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $APUS up today?

Here is the latest on APUS from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

Likely catalystReverse stock splitRatio 1-for-10Effective July 24, 2026, from the latest SEC filing. Read it →
Why is $APUS moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileLow float · 14.6M shNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201

$APUS Sentiment

Neutral
Bearish44Bullish
📰 News: 0 bull · 1 bearToday: +27.2%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$APUS Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 6h ago +23.9% vs EMA
APUS 200EMA (1m) Trending · 100 bars · L4 · +23.94% above EMA · slope +5.97%
at $7.86
Alert· 7h ago +9.3% vs EMA
APUS 50EMA (5m) Trending · 51 bars · L3 · +9.27% above EMA · slope +15.00%
at $8.25
Alert· 7h ago -2.72%
$APUS moved -2.72% (~15m high-low range 2.72%) (Level 2) at 6:25 PM ET
at $8.08
Alert· 9h ago +62.0% vs EMA
APUS 200EMA (1m) Trending · 50 bars · L3 · +62.02% above EMA · slope +16.53%
at $8.35
Alert· 9h ago +17.1% vs EMA
APUS 50EMA (1m) Trending · 50 bars · L3 · +17.10% above EMA · slope +13.53%
at $8.68
Alert· 9h ago +3.94%
$APUS moved +3.94% (~15m high-low range 3.94%) (Level 3) at 4:41 PM ET
at $8.20
News· SEC EDGAR· 15d ago
Apimeds Pharmaceuticals US, Inc. filed an 8-K: Other Material Event
News· SEC EDGAR· 63d ago
Apimeds Pharmaceuticals US, Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 84d ago
Apimeds Pharmaceuticals US, Inc. filed an 8-K: Executive / Board Change
News· SEC EDGAR· 85d ago
Apimeds Pharmaceuticals US, Inc. filed a Annual report (10-K)
News· GlobeNewswire Inc.· 93d ago Bearish
APUS Investors Have Opportunity to Join Apimeds Pharmaceuticals US, Inc. Fraud Investigation with the Schall Law Firm

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

APUS stock FAQ

Why is $APUS up today?

Here is the latest on APUS from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.

What is the APUS stock price today?

APUS last traded at $8.00, up 27.19% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does APUS report earnings?

Apimeds Pharmaceuticals US, Inc. (APUS) is next expected to report earnings on Tuesday, August 18, 2026, about 21 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live APUS alerts?

The APUS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged APUS 2 times in the last 30 days.

What exchange is APUS on?

APUS (Apimeds Pharmaceuticals US, Inc.) trades on XASE, with a market cap of about $9M.

Is APUS good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge APUS for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.